EarningsVRTX reported non-GAAP EPS of $4.52, which was above consensus estimates, showcasing strong earnings performance.
Financial PerformanceVertex Pharmaceuticals reported total revenue of $3.0 billion, which is 3% above consensus.
Prescription GrowthJournavx has reached approximately 110,000 prescriptions, indicating expanding hospital usage.